Goal-setting in Stroke: From Guideline Towards Implementation: a Realist Evaluation
Launched by HASSELT UNIVERSITY · Oct 2, 2023
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Goal-setting in Stroke," aims to improve the care for people who have experienced a stroke by making goal-setting a regular part of their treatment. The study will involve 155 stroke patients, their informal caregivers, and 155 healthcare professionals from hospitals and rehabilitation centers. Researchers want to see how well the goal-setting program is being used in patient care, what effects it has on patients and caregivers, and whether any changes are needed to make the program even better.
To participate, stroke patients must be at least 18 years old, speak Flemish or French, and be receiving treatment in one of the participating centers. Healthcare providers involved in patient care are also eligible, as long as they work in specific healthcare settings and speak the required languages. Throughout the study, participants can expect to answer questionnaires and take part in interviews to share their experiences. This feedback will help improve the quality of care for future stroke patients.
Gender
ALL
Eligibility criteria
- • Professional healthcare providers
- Inclusion criteria:
- • Participants are employed in hospitals, rehabilitation centres and/or private practices/primary healthcare facilities located in the provinces: Province of Flemish Brabant, Brussels, Province of Walloon Brabant, Limburg
- • Participants have a social, medical profession/background, work in the management of healthcare services or quality of healthcare
- • Participants involved (direct or indirect) in the goal-setting process of the patients
- • Participants who master the Flemish or French language
- • Adult participants (≥18 years)
- Exclusion criteria:
- • • Not giving informed consent
- • Patients
- Inclusion criteria:
- • Participants after a stroke event.
- • Residence in one of the four participating sites, in outpatient care or receive treatment in first line zone
- • Participants who master the Flemish or French language
- • Adult participants (≥18 years)
- Exclusion criteria:
- • Not giving informed consent
- • Other severe comorbidities that interfere with the rehabilitation process or goal-setting process
- • Informal caregivers
- Inclusion criteria:
- • • Informal caregiver of a stroke patient admitted to one of the four participating sites
About Hasselt University
Hasselt University is a prestigious research institution located in Belgium, renowned for its commitment to advancing scientific knowledge and innovation. With a strong focus on interdisciplinary research, the university actively engages in clinical trials that aim to address pressing health challenges. Leveraging a robust network of collaborations with healthcare professionals, industry partners, and research organizations, Hasselt University strives to translate research findings into practical applications that benefit patient care and public health. The institution is dedicated to maintaining the highest ethical standards and regulatory compliance in all its clinical research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hasselt, Limburg, Belgium
Patients applied
Trial Officials
Annemie Spooren, prof dr
Principal Investigator
UHasselt
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported